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Summary A hospital-based case-control study was conducted over 4 years in Southern France to assess the
pattern of established risk factors for breast cancer and to examine its variation according to age at diagnosis.
Cases studied (450) were women admitted to the Montpellier Cancer Institute, with histologically confirmed
primary breast carcinoma. Controls (576) were patients from a nearby hospital admitted in the early stages of
a neurological or mild psychological diseases and from a clinic for general surgery. Any patient with malignant
tumours, chronic and cardiovascular diseases were excluded. The total population globally showed the
commonly reported pattern for these risk factors. When stratified by age, the reproductive factors occurring
early in life (menarche, first full term pregnancy) were shown to be significant risk factors only in the youngest
group ofpatients and do not seem to influence risk in older women, for whom risk factors are those occurring
later in life (menopause, obesity). This suggests a complex involvement of the reproductive and socio-
demographic features with the various stages of the 'natural history' of breast cancer.
Various risk factors for breast cancer (BC) have been recog-
nised for many years. There is agreement by most authors on
a list of 'established' (Kelsey & Gammon, 1990) risk factors,
made up of reproductive and menstrual variables, socio-
economic status, family history of BC and previous benign
breast disease. These have been found in most countries
where studies have been conducted: North America (Helm-
rich et al., 1983; Lubin et al., 1987); Scandinavia (reviewed in
Ewertz et al., 1990); Western Europe (Talamini et al., 1985;
Le et al., 1984); Eastern Europe (Plesko et al., 1985); Asia
(Thein & Theen et al., 1978) and South America (Mirra et
al., 1971). However, in several studies, there is no risk in-
crease associated with some of these established factors
(Adami et al., 1980; East European Study of BC epidemi-
ology, 1990).
Different approaches can be taken to reconcile these discre-
pancies. A meta-analysis of several epidemiological data-sets,
by increasing the power of study can detect effects which are
not significant in a single study and show that these different
results can be unified (Ewertz et al., 1990). Another approach
is to stratify by age at diagnosis, since BC appears to be
different ifdiagnosed in young or in older women (de Waard,
1979). A good example which shows that discrepancies lie
more on age classes than on regional variations, is a study
conducted in Canada. A first report did not disclose either a
risk for nulliparity nor a protective effect for multiparity
(Burns et al., 1981), while a second analysis showed that in
45 and above years age group nulliparity was a strong risk
factor (Lubin et al., 1982).
The study of Quetelet index {weight (kg) << height2 (m))
as a risk factor for BC is another reason for presenting
results by age-group, since this risk factor is usually found
only in older women (Parazzini et al., 1990).
The results presented here are part of a study carried out
in Montpellier which focused essentially on nutritional fac-
tors in breast cancer and on related blood levels of liposolu-
ble vitamins and lipid parameters (Gerber et al., 1988;
Gerber et al., 1989; Richardson et al., 1989; Gerber et al.,
1990; Cavallo et al., 1991; Gerber et al., 1991; Richardson et
al., 1991).
The purpose of the present analysis was as follows: (i) to
assess reproductive and other major factors identified as
determining risk for BC: namely, age at menarche, age at
first full term pregnancy (FFTP), parity, family history of BC
in a first degree relative, history of benign breast disease
(BBD) and Quetelet index in a geographically well-defined
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population (Languedoc-Roussillon in Southern France). (ii)
to test the potential interaction between these risk factors
and age at diagnosis and, ifsuch interactions exist, to present
the risk factors within each age stratum.
Methods
Studypopulation
Subjects were interviewed between February 1983 and April
1987. Cases were women aged between 26 and 66 years old
with histologically confirmed primary carcinoma of the
breast who were hospitalised in the Montpellier Cancer Insti-
tute and had not previously undergone any therapy. The
upper age limit was chosen in order to avoid recall bias in
answering the dietary questionnaire. Controls were women of
the same age range admitted for the first time into three
different wards: neurology and neurosurgery in a nearby
hospital, general surgery in a large clinic. These women came
for a first diagnosis and hence were not being currently
treated for chronic diseases. These wards were chosen above
all because the pathologies which they treat are, on the
whole, not related to nutritional factors. We excluded from
the controls only women admitted for cardiovascular, neo-
plastic or benign breast diseases. The Montpellier Cancer
Institute is the main cancer treatment centre in the area and
is attended by patients from throughout the Languedoc-
Roussillon region, irrespective of social class. For other
diseases, patients can choose to be treated either in a hospital
or in a private clinic. For this reason, we recruited controls
both in public hospital and private clinic. Before the start of
the study, we checked that the wards from which the cases
and the controls were recruited had patients of similar age
and geographical area of residence.
Data collection
Each week the study coordinator visited the wards and
selected for interview all women on the new admissions list
satisfying the inclusion criteria of the study. The interviews
were carried out by trained medical students, who questioned
cases and controls. The interviews, presented as an inquiry
on living conditions and health, lasted 30 min on average for
cases and controls. Medical and reproductive history at the
time ofdiagnosis was recorded as well as general information
regarding demographic variables, socio-economic status,
anthropometric measurements and cigarette smoking habits,
while the dietary questionnaire covered 55 key food items
including alcoholic beverages.
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Methods ofanalysis
Age at menarche, age at FFTP, parity, menopausal status
plus age at menopause (natural vs artificial) were recorded.
We defined a positive family history of breast cancer when
there exists one or more first-degree relative (mother or
sister) with breast cancer, and a positive history of BBD
when a medical and/or histological and/or radiographical
diagnosis of fibrocystic dystrophia was reported by the
patient. To estimate body mass, we used Quetelet's index; the
chosen classes corresponded to tertiles ofthe control distribu-
tion.
The analysis was carried out with S.A.S.-PC statistical
package. The measure of association used for evaluating
effects of a potential risk factor is the odds ratios (OR),
which together with their 95% confidence intervals (CI) were
calculated following the Cornfield method (1951). For multi-
ple levels of exposure, a linear trend test distributed as a
chi-square with 1 d.f. was computed following Breslow and
Day (1980). Age at diagnosis was studied in three groups:
under 45, 45-54 and 55 years old and over. To assess
interaction with age at diagnosis and with menopausal status,
chi-square tests of homogeneity were calculated following
Breslow and Day (1980). Confounding variables were eval-
uated by stratified techniques (Mantel-Haenzel), and are con-
sidered as relevant for adjustment if the OR for the factor
being studied changes when allowance is made for the poten-
tial confounding factor. The multivariate analysis was carried
out in each age-group via multiple logistic regression to
simultaneously control for the potential confounders (Bres-
low & Day, 1980). Allowance was made for factors only if
they affected the risk estimates when included in the models
generated by logistic regression. Few patients for whom in-
Table I Distribution of cases and controls by age-group and
menopausal status
Less than
45years 45 to 54 years 55 years and over
Cases 155 (34.4%) 210 (46.7%)
Total 85 (18.9%) 82 4
Pre 74 73 206
Post lOa
Controls 199 (34.7%) 200 (30.5%)
Total 175 (34.8%) 78 3
Pre 157 121 196
Post 17b
'All with artificial menopause; b15 with artificial menopause.
formation was missing on any of the adjusting factors were
not considered in the multivariate analysis. Confidence inter-
vals were obtained from the standard error of the correspon-
ding regression coefficient.
Results
Altogether, 1,026 interviews were completed during the study
period. All cases replied; eight controls refused to participate.
No patients died before interviewing was completed. The
analysis presented here was carried out on 1,026 subjects,
comprising 450 cases and 576 controls. The control group
was composed of: 163 women (28.3%) admitted for neuro-
surgery (mostly sciatic nevritis, less frequently traumatisms or
benign tumours); 93 women (16.1%) admitted for neuro-
logical conditions (peripheral paresias and paresthesias, men-
ingitis, epilespy and other medical neuropathies); 90 women
(15.6%) admitted for headaches, asthenia and sleep dis-
orders; 86 women (14.9%) with slight psychological disorders
(as depression); 66 women (11.5%) admitted for general
surgery (gynaecological, digestive and vascular); 65 women
(11.3%) admitted for neurological diseases (such as multiple
sclerosis and Parkinson's disease, diseases which were diag-
nosed for the first time). For 15 women (2.6%), the diagnosis
was unknown.
The mean ages of cases and controls were 52.3 ± 8.7 and
49.8 ± 9.7 years respectively. Table I gives the age and meno-
pausal distributions of the women in this study, showing that
cases are significantly older then controls (Chi-square test=
22.18, P<0.0001).
Several indices of socio-economic status were examined.
Information was collected on the type (rural, urban) of area
the subjects have being living in and on their occupation. If
they were married, the occupation of their husband was also
recorded. With respect to none of these demographic vari-
ables was the risk sufficiently high, or the proportion of the
population at risk sufficiently large, to suggest that adjust-
ment for the variable had to be considered in the analysis of
other factors of interest. Only with respect to education was
any appreciable difference found. Risk rose to 1.4 (95% CI:
1.08-1.78) for women who stayed longer in school (15 years
old and more at the end of education).
Table II shows the unadjusted relative risks for BC associ-
ated with the seven variables studied, and, if relevant, the
significance of the trend test for the total population. Most
risk factors are in general agreement with those found in
literature. There is a statistically significant increased risk for
Table II Risk factors of breast cancer in total population
Age at < 13
menarche 13-14
>14
Age at FFTP <22
22-25
>25
Parity
Family history
of BC
History of
BBD
Quetelet index
0
1
2-3
>3
No
Yes
No
Yes
<21.3
21.3-24.1
>24.1
Age at natural <48
menopause 48-51
>51
Cases
(450)
176
208
66
118
148
120
59
78
248
65
416
28
384
62
118
146
181
35
86
88
Controls
(576)
205
250
109
192
170
122
85
102
274
113
551
14
532
35
188
186
195
75
94
68
aTrend calculated for parous women only.
OR
1
0.97
0.71
1.42
1.60
1.10
1.30
0.83
2.65
2.45
1.25
1.48
1.96
2.77
Trend
95% CI P value
0.74-1.27
0.49-1.02
1.03-1.95
14-2.25
0.71-1.72
0.90-1.90
0.53-1.30
0.10
0.006
NSa
1.38-5.10
1.59-3.79
0.91-1.72
1.09-2.01
1.19-3.22
1.66-4.62
0.01
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a late age at FFTP, a family history of breast cancer in a first
degree relative, a history of BBD, a high Quetelet index and
a late age at menopause. There is a lack of evidence for two
frequently reported BC risk factors, namely nulliparity and
uniparity. No significant trend of decreasing BC risk was
observed with an increasing number of full-term pregnancies,
but women with four or more children have an OR of 0.83
(95% IC: 0.53-1.3) relative to those with none. As adjust-
ment for age at the end of education did not provide any
change in the ORs for the factors under study, this variable
was not considered to be a confounder.
Then we studied the interaction of these risk factors with
age at diagnosis and with menopausal status, according to a
test of homogeneity made to check the equality of the rela-
tive risks estimated in the three age groups, under 45, 45-54
and 55 and over, and in the pre- and post-menopausal
groups. In addition, a trend test was conducted to evaluate a
potential linear variation of risks with advancing age.
There are significant interactions and trends in at least one
stratum between age at diagnosis and age at menarche, age
at diagnosis and familial history of BC, and a significant
trend between age at diagnosis and a history of BBD (Table
III).
When interaction with menopausal status has been analys-
ed (Table IV), results are in the same line, but carry less
strength: there are significant interactions between meno-
pausal status and age at FFTP, and age at menarche,
although none of the OR are significant in this later case.
There is a borderline interaction with a history of familial
BC.
Therefore we chose to describe the distribution of the risk
factors by age group. Tables V to VII present the adjusted
relative risks for the different factors. Adjustment for the
other variables of each table and age at the end of education
were made only if the OR for the variable under study
changed when the potential confounding factor was intro-
duced in the model. Menopausal status could be studied in
the 45-54 age group while the age factor at natural meno-
pause was studied in the older group only.
According to the results of the interaction tests, most of
the ORs varied with age at diagnosis. The protective effect of
menarche occurring after 12 years was found for the young-
est women (under 45) only, while in the oldest group (55 and
over) the pattern of risk was complex, with early and late
menarche being protective. A FFTP after 25 years was a risk
factor in the under 45 group only. Having more than three
Table III Interaction of age at diagnosis and established risk
factors
Age at diagnosis Homogeneity Trend
<45 45-54 >54 P value P value
Age at < 13 1 1 1
menarche 13-14 0.44 0.78 1.89 0.001 0.06
> 14 0.35 0.84 0.74
Age at FFTP <22 1 1 1
22-25 1.64 1.20 1.41 NS NS
>25 2.25 1.04 1.55
Parity 0 1 11 1
1 1.05 0.92 1.20
2-3 1.57 1.49 0.96 NS NS
>3 0.57 0.92 0.58
Family history No 1 1 1
of BC Yes 0.78 2.98 8.04 0.05 0.002
History of No 1 1 1
BBD Yes 4.30 2.63 1.94 NS <0.001
Quetelet index <21.3 1 1 1
21.3-24.1 0.81 1.16 1.42 NS NS
>24.1 1.05 1.21 1.54
Table IV Interaction ofmenopausal status and established risk factors
Premenopausal Postmenopausal Homogeneity
398 623 P value
Age at < 13 1 1
menarche 13-14 0.56 1.33 0.004
> 14 0.53 0.75
Age at FFTP <22 1 1
22-25 1.50 1.27 0.009
>25 2.03 1.25
Parity 0 1 1
1 0.94 1.10
2-3 1.37 1.10 NS
> 3 0.81 0.64
Family history No 1 I
of BC Yes 1.08 4.19 0.10
History of BBD No 1 1
Yes 3.57 1.89 NS
Quetelet index <21.3 1 1
21.3-24.1 0.80 1.51 NS
>24.1 0.96 1.61
Age at natural <21.3 1
menopause 21.3-24.1 - 1.88
>24.1 2.55
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Table V Risk factors in less than 45 year old women
Cases Controls Trend
(85) (172) OR 95% CI P value
Age at < 13 43 59 1
menarche 13-14 31 88 0.44 0.25-0.77 0.003
> 14 7 25 0.35 0.14-0.88
Age at FFTB8 <22 24 69 1
22-25 29 51 1.69 0.84-3.39 0.01
>25 18 23 2.93 1.27-6.79
Parityb 0 12 31 1
1 15 37 0.89 0.35-2.23
2-3 54 89 1.30 0.60-2.82 NS
>3 4 18 0.47 0.11-1.90
Family history No 79 165 1
of BCb Yes 3 8 0.50 0.11-2.14
History of No 60 157 1
BBDC Yes 23 14 4.11 1.96-8.64
Quetelet <21.3 40 80 1
indexb 21.3-24.1 21 52 0.85 0.44-1.64 NS
>24.1 22 42 1.22 0.63-2.38
aAdjusted for age at menarche and benign breast disease; bAdjusted for benign breast
disease; cAdjusted for age at menarche.
Table VI Risk factors in 45 to 54 year old women
Age at < 13
menarche8 13-14
>14
Age at FFTB <22
22-25
>25
Paritya 0
1
2-3
>3
Family history No
of BC' Yes
Cases
155
56
69
30
48
53
33
19
21
89
26
Controls
196
61
96
39
65
60
43
29
35
91
43
OR
1
0.92
0.87
1.19
1.04
1
0.91
1.47
0.99
145 192 1
9 4 3.24
History of No 125 181 1
BBDb Yes 29 16 2.29
Trend
95% CI P value
0.56-1.51
0.47-1.60
0.71-2.02
0.58-1.87
0.40-2.06
0.75-2.88
0.46-2.18
NS
NS
NS
0.95-11.02
1.18-4.45
Quetelet
index'
<21.3
21.3-24.1
>24.1
Menopausal Pre
statusc Post
44
56
53
64
70
64
1.25
1.38
82 78 1.71
73 121 1
0.73-2.13
0.80-2.37
1.10-2.66
NS
'Adjusted for benign breast disease and menopausal status; bAdjusted for familial
history of BC and menopausal status; cAdjusted for benign breast disease and familial
history of BC.
children seemed to have a protective role in the youngest and
the oldest women. The ORs are non significant in both cases,
but the trend is significant in the oldest group, giving more
strength to this factor in this later group. On the contrary, a
non significant detrimental effect of having two to three
children is shown in the two youngest groups. The strong
risk associated with having a first degree relative with BC
increased with age at diagnosis after 45 years. However, if an
upper limit of 40 years is selected for the youngest group an
elevated OR is also found associated with the family history
of BC (OR = 2.7, 2/38 cases against 1/52 controls). The risk
associated with BBD (fibrocystic dystrophia) history is not
significant in the older women group (>55). In the two
youngest groups, the risk is statistically significant and in-
creases with decreasing age at diagnosis. There is a non-
significantly increased OR with an increasing Quetelet index
in each age group except for the youngest one, who shows an
OR above one only in the highest class. The values of the
ORs increase with age for the same index class. The meno-
pausal status could be analysed only in the intermediary
group: premenopause is significantly associated with an ele-
vated OR. This is in line with the increased risk associated
with increasing age at menopause in the oldest group (OR
and trend are significant).
Discussion
As in all hospital-based case-control studies, selection bias
cannot be totally excluded. For example, one study reported
that the use of hospital controls led to the exaggeration of
the age at first birth effect and also that hospitalised women
tend to have more children than women in the normal
population (Lund, 1989). In order to limit geographical bias,
controls and patients were recruited from the same region
(Richardson et al., 1991). With regard to bias related to the
diseases of controls, first, it can be said that as a whole the
pathologies displayed in the control group are not linked to
the established BC risk factors. Then, the controls being
recruited in three wards with different specialisation covering
a large range of pathologies, this should minimise an even-
tual bias linked to a specific pathology. Besides, there is anRISK FACTORS FOR BREAST CANCER 923
Table Vn Risk factors in 55 year old women and over
Age at < 13
menarchea 13-14
>14
Age at FFTBb <22
22-25
>25
Parityc 0
1
2-3
>3
Family history No
ofBCd Yes
History of No
BBDe Yes
Cases
210
73
108
29
46
66
69
28
24
105
35
Controls
195
84
66
45
58
59
56
42
30
94
52
OR
2.04
0.80
1.58
1.38
1.17
1.04
0.57
192 193 1
16 2 8.15
199 193 1
10 5 1.09
Trend
95% CI P value
1.29-3.21
0.45-1.43
0.91-2.75
0.80-2.38
0.54-2.49
0.55-1.97
0.27-1.19
NS
NS
0.02
1.80-36.89
0.34-3.49
Quetelet
index'
Age at
natural
menopause&
<21.3
21.3-24.1
>24.1
<48
48-51
>51
34
69
106
20
67
81
44
63
89
39
60
53
1.20
1.43
1.94
3.18
0.66-2.20
0.81-2.52
1.16-3.25
1.87-5.41
NS
0.0001
aAdjustedforfamilialhistoryofBCandageattheendofeducation;bAdjustedforageat
menarcheand familial history ofBC; cAdjusted forage atmenarche and ageat theend of
education; dAdjusted on age at menarche and age at menopause; eAdjusted for age at
menarche, familial history of BC, age at the end of education and age at menopause;
fAdjusted for age at menarche, familial history of BC and age at the end ofeducation.
advantage of hospital based case-control studies: it is expect-
ed that they have similar motivation for answering since both
cases and controls are patients in a hospital.
In our total sample, the reproductive factors have shown
the same pattern as that described in other populations all
over the world (Helmrich et al., 1983; Lubin et al., 1982;
Ewertz et al., 1990; Talamini et al., 1985; Le et al., 1984;
Plesko et al., 1985; Thein-Hlaing et al., 1978; Mirra et al.,
1971). However, parity was not found completely in line with
what has been generally reported, since have two or three
children was associated with a somewhat elevated OR com-
pared with having no child and have more than three child-
ren was not significantly associated with a protective effect.
This has also been found by Boyle (1988) and Burns et al.
(1981).
The striking finding of our study is the age-specificity of
the various risk factors for BC. This is shown both by the
results of interaction tests and the variation of ORs across
the three age groups. Although some interaction tests are not
significant, it should be noted that these tests are not very
powerful. Our strategy of not systematically adjusting for age
but to consider first if age at diagnosis is an effect-modifier
has been shown to be a relevant rationale. To be complete,
interaction tests were also carried between menopausal status
and the various risk factors. The menopausal status provides
information on the hormal status of the subject and is of
interest. However, because of the uncertainty related to the
precise age and to the hormonal unbalance of the perimeno-
pausal state, classes are partly inaccurate. The only clear
indication brought up by the results in Table IV are related
to age at FFTP.
The risk factors associated with BC before 45 years of age
are events occurring during the first part of reproductive life:
early age at menarche, late age at first full term pregnancy
and history of benign breast disease. On the contrary, these
risk factors were not found significantly associately with BC
in older women. With regard to the two former, the findings
are in general agreement with previous reports (Mirra et al.,
1971; Ewertz & Duffy, 1988; Negri et al., 1990; Ewertz et al.,
1990; Tulinius et al., 1990). Although non statistically signi-
ficant, our results suggest that having two or three children in
young women at diagnosis is associated with greater risk.
This has also been observed by Kvale et al. (1987); Negri et
al. (1990) and Williams et al. (1990). Since we do not have
information about the date of the last pregnancy, we cannot
say for sure that this increased risk is related to the detrimen-
tal effect of a recent pregnancy (Bruzzi et al., 1988). How-
ever, it is very likely, because the increased risk is restricted
to the youngest groups.
In the older groups, the risks were quite different. Age at
natural menopause and family history of BC are significantly
associated with BC. Having more than three children is
associated with lower OR and there exists a significant trend
of decreasing risk with increasing number of children. The
OR for the highest class of Quetelet index is above one and
higher than in the youngest age group. Obviously, meno-
pause is an event occurring at the end of the reproductive life
and multiparity as well as increased body mass index are
generally concomittant to an older age. Thus, these risk
factors for elderly women are events occurring late in life.
The question of a difference between BC in young and
older women has often been evoked in the literature since the
pioneer work of de Waard (1979), which was extended later
(Lubin et al., 1982; de Waard, 1988; Bouchardy, 1990). This
difference is generally associated with menopausal status. Our
results suggest that the length of life elapsed before diagnosis
may be a major determinant of which factors will be risk
factors or not. This is generally true when considering risk
factors which are dependent themselves upon the time of
occurrence in life. If we assume that cancer initiation, induc-
ed by either an exogenous or endogenous exposure occurs
early in life, one can reasonably expect that an early men-
arche which causes proliferation of susceptible cells will in-
crease the risk of BC development. In the same line, an early
first full term pregnancy which induces cell differentiation,
thus decreasing susceptibility, will be protective. The aging of
the breast tissue at menopause is a protective factor which
will be effective in as much as it occurs close to cell transfor-
mation, that is to say near to the time of initiation. Thus, the
somatic mutation leading to cancer induction would have
occurred early in life in young BC cases and late in life, in
elderly BC cases. Why this difference is generally associated
with distinct prognostic features remains to be determined. It
can be proposed that early induction carried an intrinsic
tendency to aggressivity contrarily to late induction; alterna-
tively, different clinic and prognostic features may result from924 C. SEGALA et al.
the physiological status of the host: in young women oestro-
gens which are known as growth factors inducers, show
higher levels than in older women. It should be noted that
the only significant interaction with menopausal status (that
is to say with active hormonal status) has been found with
age at FFTP indicating that a late age at FFTP might be
detrimental not only because breast tissue differentiation
occurs late in life, but also because initiation occurs in a
growth stimulating environment. Reciprocally, the cellular
and metabolic properties of a senescent organism may be less
facilitating for cell proliferation.
Our finding on a BC risk associated to family history
seems to contradict our assumption. If familial BC are attri-
buted to inheritance of dominant genes, one should expect to
find this risk factor associated with BC in young women
(Lynch & Watson, 1990). Indeed, when examining under 40
year old women, we found an OR above two; however, other
reports showed that this risk factor exists in older age groups
(Burns et al., 1981; Mettlin et al., 1990). This suggests hetero-
geneity in familial cases as hypothesised by Andrieu et al.
(1989). One model of inheritance implies gene(s) with high
penetrance in which environment should be less important.
This model would be associated with BC risk at a young age.
A second possible model assumes that one or several com-
mon alleles would increase sensitivity to environmental fac-
tors: this model would be associated with BC risk at an older
age since a long period of time will allow for the effect of
more endogenous and exogenous factors.
Our data suggest that ifa woman with a fibrocystic dystro-
phia gets to over 55 years of age, there is no or little risk that
BC develops. It can be said that this type of BBD is related
to an elevated oestrogen synthesis which physiologically
decreases at menopause. Thus this BBD may merely reflect
an hyperoestrogenemia responsible for the increased risk.
The alternative hypothesis would be a direct cellular effect of
the histological alteration.
One finding in our study remains without satisfactory ex-
planation: a significantly high OR has been found associated
with an age at menarche in the intermediary class (13-14).
Schatzkin et al. (1987) reported the same finding in a case-
control study on black women in the USA and concluded
that their results were inconsistent. Also, older women who
do not remember their exact age at menarche may tend to
give such ages, since they are the most frequent (recall bias).
In summary, in spite of certain limitations inherent in
case-control studies and to the size of our population, our
results suggest that most of BC risk factors are age-specific.
This is consistent with the multistage theory of carcino-
genesis, each factor playing a specific role in conjunction with
the stage of development of cancer. Therefore to distinguish
pre- and post-menopausal cancer is not as relevant as to
describe BC risk factors in each age stratum.
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